Epidarex Capital (Epidarex), an early-stage, transatlantic life science venture fund, has appointed Dr William R Sellers, William Burns and Dr. Frank M Armstrong to its advisory board. Epidarex is a leading investor in high growth life science and health technologies in under-ventured markets. The advisory board provides strategic guidance and advice to Epidarex and its transatlantic portfolio of 14 early-stage life science companies.   Kyp Sirinakis, Managing Partner and co-founder of Epidarex, says: “As a leading, early-stage venture capital firm, Epidarex builds high-growth life science companies in under-ventured markets. We are delighted to welcome our new advisory board members and

Waterland Private Equity Investments has moved to a new permanent UK office and unveiled a new UK team that is looking to partner with entrepreneurial companies in the UK and Ireland. The European-wide private equity fund manager recently closed its seventh fund (WPEF VII), at EUR2 billion, after less than two months of fundraising, and attracted investment from Europe, the US, the Middle East and Asia.    Waterland UK focuses on sourcing buy-and-build opportunities across the UK and Ireland, typically concerning companies with EBITDA of between GBP3 million and GBP10 million. Waterland is an active shareholder across its portfolio, playing

Kewsong Lee and Glenn A Youngkin are to become Co-Chief Executive Officers of The Carlyle Group, while Peter J Clare will become Co-Chief Investment Officer alongside current CIO William E Conway, Jr. Carlyle’s current Chairman Daniel A D’Aniello will become Chairman Emeritus and continue to serve on the Carlyle Board and Executive Group, while current Co-CEOs David M. Rubenstein and William E. Conway, Jr. will become Co-Executive Chairmen of the Board and continue to serve on the Carlyle Executive Group. Youngkin, Lee and Clare are all joining the Carlyle Board of Directors Conway, D’Aniello and Rubenstein, say: “These promotions ensure

Adams Street Partners, a private markets investment management firm, has appointed Alex Kessel as a Principal on its Co-Investment Team. Kessel joins a growing, dedicated global team lead by David Brett, Partner and Head of Co-Investment at Adams Street Partners. Kessel will be actively involved in the sourcing, screening, execution, monitoring and exiting of growth and later-stage co-investments.   Before joining Adams Street, Kessel was a Principal at Baird Capital, the direct private investment arm of Robert W. Baird & Co, where he co-led the healthcare sector strategy and also had experience in the technology and services, and industrial sectors. Prior to Baird

Sell-side M&A advisor firm Cavendish Corporate Finance has promoted corporate finance professional Jon Edirmanasinghe to Partner. Edirmanasinghe covers a variety of sectors having completed transactions across TMT, Consumer, Healthcare, Financial Services and Business Services. He joined Cavendish in October 2013 as an Executive and his promotion to Partner just four years later is a testament to the outstanding quality of his work and performance in this time.   Prior to joining Cavendish, Edirmanasinghe was a Manager at Ernst & Young’s Financial Services Office in the Cayman Islands for three years, focusing on the hedge fund and private equity sectors. His previous

Muller’s appointment is part of Capzanine’s desire to institutionalise its relationship with its growing number of investors, providing them with a designated point of contact on a daily basis to help guide their investment decisions. Muller says: “My role is to establish and develop a close and valuable relationship with our investors, offering insightful, responsive discussion, and remaining at their disposal at all times to answer any questions they may have.”   Muller has extensive experience with institutional investors. He began his career in 1997 as a stockbroker in London, before joining the buy side in 2001 as Head of

Philippe de Gaspé Beaubien III has launched DGC Capital, a private investment firm that seeks to promote innovative, high-potential companies in the information and communication technologies, technology, and advanced manufacturing sectors. The firm will be headed by Françoise E Lyon (pictured), a seasoned executive with more than 20 years of experience in finance.   “We want to contribute to economic growth by attracting foreign capital and helping companies with disruptive technologies go international,” says Lyon, DGC Capital’s new President and Managing Partner. “By bringing together actors that can form strategic alliances with these game-changing companies, DGC Capital wants to be

B Capital Group, a global venture capital firm that invests in pioneering healthcare, fintech, industrial logistics, and consumer enablement companies that are scaling worldwide, has made key appointments to its core executive team, including Howard Morgan as Chairman and Joe Davis as Vice Chairman. These appointments by B Capital Group will enable the firm to enhance its global-first mentality, blaze a new trail to identify transformative companies, and build enduring businesses that will bridge the gap between startups and corporations, further accelerating their path to scale and success.   Eduardo Saverin and Raj Ganguly, Co-Founders & Partners of B Capital

Revelstoke Capital Partners, a Denver-based private equity firm, has expanded its senior investment team with the addition of Eric A Shuey as Managing Director. Shuey will be responsible for new investment sourcing, transaction execution and post-investment monitoring and oversight. “We are very excited to have Eric join Revelstoke as a Managing Director. He has the rare blend of a strong track record in both direct investing and successfully managing and operating businesses. We look forward to him delivering that expertise and judgement to our existing and future portfolio of companies,” says Simon Bachleda, Managing Partner at Revelstoke.   Russell Cassella,